In the non-T2DM group with obesity, the level of leptin in the blood significantly correlated with the treatment response; the mean leptin level in the blood of responders (73.05 ng/ml) was lower than that in non responders (125.99 ng/ml; p = 0.018). This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.